跳至主要内容
临床试验/NCT01282203
NCT01282203已完成不适用

Evaluation of VIMA With SEVOrane in Adult Patients Required General Anesthesia fOr Surgery in TErms of Quality of Anesthesia and Its Influence on Cardiovascular sysTem In commON Clinical Practice (SEVOPROTECTION)

AbbVie (prior sponsor, Abbott)12 个研究点 分布在 1 个国家目标入组 1,122 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,122
试验地点
12
主要终点
Time to Awakening of Patients

研究概览

简要总结

The main objective of this post-marketing observational study is to collect data from the use of general anesthesia in patients undergoing any surgery to create local recommendations. These data will be based on the evaluation of volatile induction and maintenance anesthesia (VIMA) with Sevorane® (sevoflurane) in adult patients requiring general anesthesia for surgery in terms of quality of anesthesia and its influence on cardiovascular system in common clinical practice in Kazakhstan.

详细描述

This post-marketing observational study will be conducted in a prospective, multi-centre format. It is a non-interventional, observational study in which Sevorane is prescribed for adult patients undergoing general surgery for induction and maintenance of anesthesia in the usual manner in accordance with the terms of the local marketing authorization. Sevorane is used for induction and maintenance anesthesia by the choice of anesthesiologist. No additional procedures (other than standard of care) shall be applied to the patients. Each patient will be observed from the start of anesthesia through anesthesia end. Markers of myocardial ischemia will be detected up to the first 24 hours after anesthesia (if available). Additionally the correlation between the experience and training background of anesthesiologists and patient related outcomes of general anesthesia with Sevorane as a single anesthetic will be assessed.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients needing general anesthesia for planned or urgent surgery for whom Sevorane is used for induction and maintenance anesthesia by the choice of anesthesiologist
  • Age greater than or equal to 18 years

排除标准

  • Known sensitivity to sevoflurane or other anesthetic containing halogen
  • Known or suspected genetic susceptibility to malignant hyperthermia
  • Receiving regional anesthetic techniques
  • Receiving intravenous anesthesia
  • A history of unexplained moderate/severe hepatic dysfunction with jaundice, fever, and/or eosinophilia in association with halogenated anesthetics

结局指标

主要结局

Time to Awakening of Patients

时间窗: Every minute after anesthesia was stopped until the patient responded to a verbal command.

Measured from the time anesthesia administration was stopped until the patient responded to a verbal command.

Anesthesiologists' Satisfaction With Using Sevorane for Induction and Maintenance Anesthesia

时间窗: Day 1

The overall satisfaction of the anesthesiologist with the inhalation anesthesia with Sevorane for each patient was assessed by means of a numerical rating scale ranging from 0 (dissatisfied) to 10 (very satisfied).

Patients' Overall Impression of Anesthesia With Sevorane

时间窗: Day 1

After awakening from anesthesia, patients were surveyed regarding their overall impression of anesthesia with Sevorane. Patients selected one of the following answers: Excellent, positive, indifferent, or other.

Time to Loss of Consciousness of Patients Administered Anesthesia

时间窗: Up to 10 minutes

Loss of consciousness was measured from the time the anesthetic was administered until loss of consciousness (loss of eyelash reflex) occurred.

Time to Extubation of Patients

时间窗: Every minute after anesthesia was stopped until extubation occurred

Time to extubation was measured from the time anesthesia administration was stopped until tracheal extubation occurred.

次要结局

  • Cardiac Troponin (if Available)(Within 24 hours after anesthesia)
  • Creatine Kinase Myocardial Isoenzyme (if Available)(Within 24 hours after anesthesia)
  • Mean Arterial Pressure(Before starting anesthesia to one hour after the surgery)
  • Systolic Blood Pressure(Before starting anesthesia to one hour after the surgery)
  • Diastolic Blood Pressure(Before starting anesthesia to one hour after the surgery)
  • Presence of Deviations in Electrocardiogram Assessments During Anesthesia(During induction and maintenance of anesthesia)
  • Correlation Between Anesthesiologists' Clinical Experience and Hemodynamic Parameters During Anesthesia(Before starting anesthesia to one hour after the surgery)
  • Heart Rate(Before starting anesthesia to one hour after the surgery)
  • Correlation Between Anesthesiologists' Clinical Experience and Time to Extubation and Awakening(Every minute after anesthesia was stopped until the patient was extubated and until the patient responded to a verbal command)
  • Anesthesiologists' Duration of Clinical Experience With Anesthesia(Baseline)

研究者

发起方
AbbVie (prior sponsor, Abbott)
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验